Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Current (2025) And Forecast (2029) Sizes Of The Artificial Intelligence (AI) In Respiratory Diseases Market?
The market size for artificial intelligence (AI) in respiratory diseases has demonstrated consistent expansion in recent years. It is anticipated to increase from $7.66 billion in 2024 to $7.98 billion in 2025, at a compound annual growth rate (CAGR) of 4.2%. The historical growth in this sector is largely due to increasing government regulations, growing environmental concerns, an increasing aging population, the development of patient-centric healthcare approaches, and a rise in healthcare infrastructure development.
The market size for artificial intelligence (AI) applied to respiratory diseases is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $9.7 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.0%. Factors driving this growth during the forecast period include the increasing incidence of respiratory ailments, the heightened demand for prompt detection and accurate diagnosis, escalating environmental contamination, increasing spending on healthcare, and ongoing research and development efforts. Key trends anticipated in the forecast period encompass advancements in technology, innovations in drug discovery and development, the adoption of tailored treatment strategies, and the expansion of telemedicine and remote patient monitoring.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
Which Drivers Are Shaping The Artificial Intelligence (AI) In Respiratory Diseases Industry’s Market Share?
The increasing problem of environmental pollution is anticipated to drive the expansion of artificial intelligence (AI) within the respiratory disease market in the future. Environmental pollution is defined as the introduction of substances or energy into the environment at a pace exceeding its capacity for harmless dispersion or storage. AI’s application in respiratory diseases can considerably lessen environmental pollution’s effects on respiratory health by providing real-time surveillance, individualized risk evaluations, well-informed choices, and novel approaches for both people and populations. For example, data from June 2024, provided by the US Energy Information Administration, a governmental body in the US, indicated that CO2 emissions reached 35.72 billion metric tons in 2021, subsequently rising to 38.50 billion metric tons in 2022. Consequently, the rise in environmental pollution is stimulating the development of artificial intelligence (AI) in the respiratory disease market.
What Are The Key Segments In The Artificial Intelligence (AI) In Respiratory Diseases Market?
The artificial intelligence (AI) in respiratory diseasesmarket covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease; Interstitial Lung Disease; Pulmonary Infection
3) By End Use: Hospital; Diagnostic Centers; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging; Thoracic Imaging; Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT); Low-Dose CT; Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking; Medication Adherence Monitoring; Quality Of Life Assessments
What Long-Term Trends Will Shape The Future Growth Of The Artificial Intelligence (AI) In Respiratory Diseases Industry?
Leading companies active in the artificial intelligence (AI) in the respiratory diseases market are developing innovative products, such as N-Tidal devices, to monitor patients’ tidal breathing. The N-Tidal device quantifies the volume of air exchanged during normal breathing, offering crucial information regarding lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, launched N-Tidal, a regulated AI technology specifically for chronic obstructive pulmonary disease (COPD) diagnosis and management. This technology integrates N-Tidal’s CO2 sensor data with an artificial intelligence platform to measure changes in lung function, aiming to refine the diagnosis and management of this particular respiratory condition. Clinical studies have showcased the technology’s high accuracy, and it is projected to revolutionize the diagnostic process for respiratory diseases. This introduction represents a significant stride in leveraging AI for respiratory disease assessment, presenting a more comfortable and efficient substitute for current diagnostic tests.
Who Are The Major Companies Operating In The Artificial Intelligence (AI) In Respiratory Diseases Market?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.
Download The Full Report For Exclusive Market Findings:
Which Region Shows The Highest Potential For Future Expansion In The Artificial Intelligence (AI) In Respiratory Diseases Market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Artificial Intelligence (AI) In Respiratory Diseases Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Respiratory Diseases Market 2025, By The Business Research Company
Artificial Intelligence Of Things Aiot Global Market Report 2025
Artificial Intelligence In Cancer Diagnostics Global Market Report 2025
Artificial Intelligence Ai Engineering Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model